Biomarkers Market Size & Share, Sector / Industry Report & Analysis 2020, & Forecast 2021-2026 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global Biomarkers Market


The global Biomarkers market size is projected to reach US$ 113.96 billion by 2026, from US$ 52.74 billion in 2020, at a CAGR of 13.7% during 2021-2026. Technological advancements in development of biomarker-based diagnostics are likely to contribute to the expansion of the market.

Increase in global disease burden, especially with high prevalence of cancer, diabetes, cardiovascular disorders, and other chronic diseases supported by unhealthy diet, lack of exercise, and a sedentary lifestyle, has been a major factor driving the market growth. According to the World Health Organization (WHO), the aforementioned diseases accounted for more than 50% of 56.9 million deaths globally, in 2016.

Technological advancements have made it possible to combine biomarkers with novel drugs for accurate diagnosis and improved treatment. For instance, biomarkers are used for the treatment of neurological diseases by tracking brain health through measurement of biomolecules. Recent developments, such as biomarker signatures, are making neurological diseases more treatable resulting in non-invasive testing, faster drug development, and early diagnosis.
The introduction of Clinical Laboratory Improvement Amendments (CLIA) waived tests for biomarkers is expected to significantly drive market growth. Government initiatives aimed at reducing healthcare expenses via personalized medicines in an attempt to focus on prevention and early detection of diseases is further anticipated to propel growth.

Market Segmentation, Outlook & Viewpoint: Global Biomarkers Market

Type Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

  
Safety
  
Efficacy
  
Validation

Application Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

  
Diagnostics
  
Drug discovery & development
  
Personalized medicines
  
Others

Disease Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

  
Cancer
  
Cardiovascular Diseases
  
Neurological Diseases
  
Immunological Diseases
  
Others

Key Players, Recent Developments & Regional Insights: Global Biomarkers Market

Drug discovery segment held the largest market share in 2018, and is expected to continue leading through the forecast period. Biomarkers impact the decisions of many key players of whether to move to the next clinical development phase or not. Furthermore, pharmaceutical companies are undertaking extensive R&D initiatives to develop targeted therapeutics.

Personalized medicine is anticipated to witness lucrative growth over the forecast period, supported by high demand and consumer awareness. Moreover, increasing number of approvals for companion diagnostic tests for cancer drugs is expected to aid market growth.

Disease Insights

The cancer segment led the biomarkers market in 2018, driven by increasing demand for rapid and accurate diagnostic tools as well as rise in global incidence of cancer. Significant demand for personalized medicines and strategic collaborations between pharmaceutical and diagnostic companies is likely to drive the segment.

Cardiovascular disease is expected to be the fastest growing segment over the forecast period. Cardiovascular diseases are the leading cause of mortality and morbidity in U.S. Companies are currently focusing on identification of cardiac biomarkers as they provide increased understanding of the pathophysiology of such conditions.

Regional Insights

North America led, by contributing more than 41.0% to the overall market share in terms of revenue in 2018, driven by rising disease burden and favorable government initiatives. Presence of regulatory entities as well as key manufacturers is expected to foster the growth of biomarker-based drug development in near future.
Asia Pacific is estimated to expand at a lucrative CAGR of over 16.0% during the forecast period. Some factors responsible for the growth are local presence of leading biomarker companies and increasing R&D investment in developing countries. Moreover, the cost of clinical trials in developing countries is lower than that in developed countries. This factor is anticipated to bode well for regional market growth.

Biomarkers Market Share Insights

Some key market players include F. Hoffmann-La Roche Ltd.; Abbott.; Agilent Technologies, Inc.; Epigenomics AG; Johnson & Johnson Services, Inc; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Siemens Healthcare Private Limited; and Qiagen.

Key players adopt various strategies such as mergers and acquisitions, new product developments, and initiatives to promote awareness to maintain their market share.  For instance, in May 2017, the U.S. Food and Drug Administration (FDA) approved Roche Diagnostics biomarker assay for bladder cancer. Biomarker assay test evaluates the status of patient PD-L1 by using both immune cell staining and tumor cell staining and scoring within the tumor.

Key Insights Covered: Global Biomarkers Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Biomarkers industry.
2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Biomarkers industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Biomarkers industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Biomarkers industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Biomarkers industry.

Research Methodology: Global Biomarkers Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other